Sergei A. Roumiantsev, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Flutter | 1 | 2017 | 263 | 0.510 |
Why?
|
| Electric Countershock | 1 | 2017 | 534 | 0.480 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2017 | 789 | 0.440 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2004 | 689 | 0.320 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2022 | 341 | 0.300 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2004 | 2455 | 0.240 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2004 | 185 | 0.230 |
Why?
|
| src Homology Domains | 2 | 2001 | 364 | 0.230 |
Why?
|
| Point Mutation | 3 | 2002 | 1624 | 0.210 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2002 | 434 | 0.210 |
Why?
|
| Lymphoma, T-Cell | 1 | 2004 | 299 | 0.200 |
Why?
|
| Diazoxide | 1 | 2021 | 57 | 0.190 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2023 | 781 | 0.180 |
Why?
|
| Oncogene Proteins | 1 | 2004 | 749 | 0.170 |
Why?
|
| Growth Charts | 1 | 2020 | 61 | 0.170 |
Why?
|
| Tyrosine | 2 | 2004 | 1462 | 0.170 |
Why?
|
| Infant, Premature | 3 | 2023 | 2045 | 0.160 |
Why?
|
| Myeloproliferative Disorders | 1 | 2004 | 606 | 0.150 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2019 | 214 | 0.150 |
Why?
|
| Fetal Diseases | 1 | 2022 | 903 | 0.150 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 582 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 2917 | 0.140 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1660 | 0.140 |
Why?
|
| Leptin | 1 | 2024 | 1600 | 0.130 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2019 | 306 | 0.130 |
Why?
|
| Patient Care Management | 1 | 2017 | 306 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2022 | 1178 | 0.120 |
Why?
|
| Infant, Newborn | 7 | 2023 | 25628 | 0.110 |
Why?
|
| Piperazines | 1 | 2002 | 2488 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4554 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 3799 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2010 | 9647 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2004 | 5023 | 0.090 |
Why?
|
| Pyrimidines | 1 | 2002 | 2943 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2019 | 1887 | 0.080 |
Why?
|
| GRB2 Adaptor Protein | 2 | 2004 | 103 | 0.080 |
Why?
|
| Critical Illness | 1 | 2019 | 2670 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2019 | 3461 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1730 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 2004 | 20 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2004 | 2943 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2017 | 6442 | 0.060 |
Why?
|
| Phospholipase C gamma | 1 | 2004 | 128 | 0.060 |
Why?
|
| Chromosome Breakage | 1 | 2004 | 173 | 0.060 |
Why?
|
| Pluripotent Stem Cells | 1 | 2010 | 795 | 0.060 |
Why?
|
| Fatty Acids, Volatile | 1 | 2024 | 102 | 0.060 |
Why?
|
| Type C Phospholipases | 1 | 2004 | 292 | 0.060 |
Why?
|
| Piperacillin | 1 | 2022 | 41 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2004 | 250 | 0.050 |
Why?
|
| Telemedicine | 1 | 2020 | 2872 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2004 | 460 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 12961 | 0.050 |
Why?
|
| Obesity | 1 | 2024 | 12746 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 3 | 2004 | 3848 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2001 | 146 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2002 | 365 | 0.050 |
Why?
|
| Leukemia, B-Cell | 1 | 2001 | 86 | 0.050 |
Why?
|
| Leukemia, Experimental | 1 | 2001 | 246 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2002 | 8436 | 0.050 |
Why?
|
| Lung | 1 | 2019 | 9857 | 0.050 |
Why?
|
| Phosphotyrosine | 1 | 2001 | 457 | 0.040 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2022 | 339 | 0.040 |
Why?
|
| Interleukin-3 | 1 | 2001 | 444 | 0.040 |
Why?
|
| California | 1 | 2023 | 1402 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13693 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3617 | 0.040 |
Why?
|
| Proteins | 2 | 2004 | 6100 | 0.040 |
Why?
|
| Pulmonary Surfactants | 1 | 2019 | 162 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2004 | 1420 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2001 | 3702 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2022 | 729 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2010 | 12207 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2001 | 1264 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2019 | 690 | 0.040 |
Why?
|
| Prognosis | 1 | 2017 | 29060 | 0.040 |
Why?
|
| Benzamides | 1 | 2002 | 1379 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2002 | 1608 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2004 | 1581 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2021 | 1851 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2001 | 810 | 0.030 |
Why?
|
| Leukemia | 1 | 2004 | 1510 | 0.030 |
Why?
|
| Protein Binding | 3 | 2004 | 9384 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2004 | 2938 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2021 | 707 | 0.030 |
Why?
|
| Mice | 5 | 2024 | 81201 | 0.030 |
Why?
|
| Intestines | 1 | 2024 | 1924 | 0.030 |
Why?
|
| Humans | 11 | 2023 | 744366 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2004 | 2948 | 0.030 |
Why?
|
| Infant | 3 | 2020 | 35134 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2022 | 2901 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 2513 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 1265 | 0.030 |
Why?
|
| Female | 6 | 2022 | 380193 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2022 | 77460 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 1520 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 6386 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2022 | 2509 | 0.020 |
Why?
|
| Male | 5 | 2021 | 350115 | 0.020 |
Why?
|
| Animals | 6 | 2024 | 168768 | 0.020 |
Why?
|
| Parents | 1 | 2023 | 3405 | 0.020 |
Why?
|
| Cell Line | 2 | 2001 | 16000 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 436 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2004 | 23404 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 895 | 0.020 |
Why?
|
| Stem Cells | 1 | 2001 | 3567 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 767 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 3444 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2020 | 41005 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2022 | 4600 | 0.020 |
Why?
|
| Diet | 1 | 2024 | 7937 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 13814 | 0.020 |
Why?
|
| Comorbidity | 1 | 2019 | 10388 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7182 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 15535 | 0.010 |
Why?
|
| Research Design | 1 | 2020 | 5984 | 0.010 |
Why?
|
| Incidence | 1 | 2021 | 20952 | 0.010 |
Why?
|
| Blotting, Far-Western | 1 | 2001 | 4 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16367 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13286 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 18034 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 2418 | 0.010 |
Why?
|
| Catalysis | 1 | 2001 | 762 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1284 | 0.010 |
Why?
|
| Base Sequence | 1 | 2010 | 12797 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1802 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 18111 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 3646 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 2839 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39052 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 6111 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 53290 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 19233 | 0.010 |
Why?
|
| Ligands | 1 | 2001 | 3282 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4751 | 0.010 |
Why?
|
| Risk Factors | 1 | 2021 | 72296 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 6476 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11486 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3773 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2001 | 1418 | 0.010 |
Why?
|
| Child | 1 | 2019 | 77709 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 163288 | 0.000 |
Why?
|